Positiv
●
Seeking Alpha
●
vor 4 Monaten
Mistras remains a 'Buy' as margin expansion, revenue diversification, and O&G recovery drive a compelling upside case. MG's Vision 2030 strategy is delivering: non-O&G segments sustain growth, while O&G could reaccelerate with sector Capex cycles. Adjusted EBITDA margin improved to 12.3%; management guides FY 2026 revenue of $730–$750M and EBITDA of $91–$93M, prioritizing deleveraging.